Floatz logo

TESTOSTERONE UNDECYLATE

Ovary Cancer

Aminex Therapeutics, Inc.Small moleculePhase 1/2Active
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
89/ 100

Competitive context

10 Active assets in the Ovary Cancer cohort.

Asset / SponsorPhaseRating
Tisotumab Vedotin
Seagen Inc.
Phase 2BB
TECHNETIUM-99
Institut de Cancérologie de Lorraine
Phase 3B
Np-G2-044
Novita Pharmaceuticals, Inc.
Phase 2/3B
Mirvetuximab Soravtansine-GYNX
University of Colorado, Denver
Phase 2CCC
Hbi 0201-Eso Tcrt
Hadassah Medical Organization
Phase 1/2CC

View all 14 →

Same molecule, other indications

TESTOSTERONE UNDECYLATE is also rated in:

hypogonadotropic hypogonadismDormant
A
Indicative ·
82 / 100
View asset →
type 2 diabetes mellitusDormant
BBB
Indicative ·
73 / 100
View asset →
abdominal obesity-metabolic syndromeDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →